Yes, high drug prices are an issue but at least there's some certainty that wholesale cuts in prices through Medicare/Medicade price negotiation are off the table (for the moment?) and the risk-reward equation as determined by market forces will prevail, which will ensure investment in R&D to bring new drugs and generics to market. (No wonder someone ploughed $A10M into MYX late on Friday)
http://www.chicagotribune.com/business/ct-trump-drug-costs-20170202-story.html
http://www.vox.com/policy-and-politics/2017/1/31/14453740/trump-medicare-prescription-drugs
Trump flips on US pharma prices
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.65 |
Change
0.040(0.87%) |
Mkt cap ! $390.4M | |||
| Open | High | Low | Value | Volume |
| $4.65 | $4.66 | $4.55 | $202.4K | 44.28K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 2261 | $4.63 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.65 | 399 | 5 |
View Market Depth
| Last trade - 11.18am 15/10/2024 (20 minute delay) ? |
| MYX (ASX) Chart |